Quick Answer
Celularity Inc reported Diluted EPS of $2.64 per share (loss) for fiscal year 2024.
Celularity Inc Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$2.64 | +76.0% |
| 2023 | -$11.02 | -1260.0% |
| 2022 | $0.95 | +163.8% |
| 2021 | -$1.49 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.88 | -20.5% | +13.7% |
| June 30, 2025 | -$1.02 | -240.0% | -21.4% |
| March 31, 2025 | -$0.84 | +18.4% | -15.1% |
| September 30, 2024 | -$0.73 | +85.3% | -143.3% |
| June 30, 2024 | -$0.30 | +89.0% | +70.9% |
| March 31, 2024 | -$1.03 | +75.0% | +79.3% |
| September 30, 2023 | -$4.98 | -16700.0% | -83.1% |
| June 30, 2023 | -$2.72 | -950.0% | +34.0% |
- Celularity Inc showed an increase of +76.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2024 period, Celularity Inc’s diluted eps has declined by 77.2% (from $1.49 per share (loss) to $2.64 per share (loss)).
- The most recent figure is from Celularity Inc’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: